SMYD3's Role in Head and Neck Cancer
Author Information
Author(s): Murali Madhavi, Saeed Abbas, Kim Sohyoung, Burkitt Kyunghee, Cheng Hui, Moshiri Arfa, Akhtar Jawad, Tsai Daniel, Luff Marie, Karim Baktiar, Saloura Vassiliki
Primary Institution: National Institutes of Health
Hypothesis
Does SMYD3 contribute to the progression of HPV-negative head and neck cancer through its effects on cell cycle and epithelial-mesenchymal transition pathways?
Conclusion
Depleting SMYD3 significantly reduces the growth and invasive potential of HPV-negative head and neck cancer cells.
Supporting Evidence
- SMYD3 depletion decreased cellular proliferation and clonal capacity in HPV-negative HNSCC cell lines.
- Xenografts of SMYD3 knockout tumors grew significantly slower than control tumors in mice.
- Genome-wide mapping identified direct downstream gene targets regulated by SMYD3.
Takeaway
SMYD3 is a protein that helps cancer cells grow and spread, and when we take it away, the cancer cells grow slower and are less able to invade other tissues.
Methodology
The study used siRNA and CRISPR to deplete SMYD3 in HPV-negative head and neck cancer cell lines and assessed the effects on cell proliferation, colony formation, and tumor growth in mouse models.
Potential Biases
Potential bias in the selection of cell lines and animal models used for the experiments.
Limitations
The study primarily focuses on in vitro and in vivo models, which may not fully replicate human disease complexity.
Participant Demographics
The study involved HPV-negative head and neck cancer cell lines derived from patients.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website